Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.


TSXV:KNE - Post by User

Bullboard Posts
Comment by VIKINGSTORMon Jan 16, 2012 1:28pm
173 Views
Post# 19408293

RE: RE: RE: Reality of doing business

RE: RE: RE: Reality of doing business

 

So you're saying that the road block to promoting "this product" ( I assume you mean all products ? ) is Gord himself ? Could the actual "road block" not be more of a function of the current economic enviroment which is seeing larger companies holding back until the smaller companies have done the tough sledding of getting regulatory approvals put through before jumping in ( which I understand is generally the case these days) ???

Is Gord to blame for that - even partially ? I truly don't know.  Is he ?

Could the submission to Health Canada on KBI be what another company is waiting for to jump in and thus allow Kane to start making SOME money ? Will this turn out to be the final "road block" that when overcome will finally give Kane the opportunity to start making SOME money ?? I sure hope so but again...I truly don't know. That's why I ask. I ask for reasonable responses not smug, snotty disjointed jabs.  ;-)

Bullboard Posts